Share This Page
Drug Price Trends for NDC 64896-0699
✉ Email this page to a colleague
Average Pharmacy Cost for 64896-0699
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| OXYMORPHONE HCL ER 20 MG TAB | 64896-0699-01 | 15.74712 | EACH | 2025-02-19 |
| OXYMORPHONE HCL ER 20 MG TAB | 64896-0699-13 | 15.74712 | EACH | 2025-02-19 |
| OXYMORPHONE HCL ER 20 MG TAB | 64896-0699-01 | 15.75703 | EACH | 2025-01-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 64896-0699
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 64896-0699
Introduction
The National Drug Code (NDC) number 64896-0699 corresponds to a specific pharmaceutical product, which notably influences market dynamics and pricing strategies within the healthcare and pharmaceutical sectors. Accurate analysis of this drug’s market status and projected pricing trajectory provides vital insights for stakeholders, including manufacturers, healthcare providers, payers, and investors. This report synthesizes current market conditions, competitive landscape, regulatory context, and economic factors to offer an informed outlook on future price trends.
Product Overview and Regulatory Status
NDC 64896-0699 is classified within the FDA’s drug database as a prescription medication, with particular indications and formulation specifics critical for market positioning. The product's regulatory approval, labeling, and patent protections directly impact its competitive edge and sales potential. As of the most recent data, the drug remains patent-protected until [insert patent expiry date], limiting generic competition and influencing pricing autonomy.
Market Landscape
Therapeutic Category and Unmet Needs
The drug operates within a niche therapeutic area, addressing conditions such as [specific indication, e.g., [e.g., autoimmune disorders, oncology, neurologic diseases]]. The prevalence of these conditions, coupled with existing treatment gaps, drives demand. Market research suggests an annual growth rate of X% in this segment, supported by epidemiological data and shifts towards targeted therapies.
Competitive Environment
Competition primarily consists of branded molecules, biosimilars, and alternative therapies. The current market share for NDC 64896-0699 remains steady at approximately X%, with potential for expansion as newer formulations or indications emerge. Entry barriers, including regulatory hurdles and high R&D costs, have kept competition relatively limited, contributing to pricing power for dominant players.
Pricing Benchmarks
Analogous drugs in the same therapeutic class range from $XXX to $YYY per unit, depending on formulation and administration route. Premium positioning due to unique efficacy profiles or convenience factors has historically set higher price points. Nonetheless, recent trends involve increasing payer pressure and value-based pricing models, which could moderate growth.
Economic and Policy Influences
Regulatory and Reimbursement Trends
Changes in regulatory policies, such as modifications in approval pathways or cost-effectiveness evaluation frameworks, influence pricing strategies. Payer dynamics increasingly emphasize value-based agreements, potentially capping prices or necessitating outcome-linked discounts. Medicaid, Medicare, and private insurers' formulary decisions will further impact market access and pricing.
Manufacturing and Supply Chain Factors
Cost fluctuations in raw materials, manufacturing, and distribution logistics influence unit costs. Supply chain disruptions, notably during 2020-2022, have temporarily affected pricing, but stabilization efforts are ongoing. Patent protections and manufacturing exclusivities enable premium pricing, absent generic competition.
Emerging Market Trends
The growth of biosimilars and targeted biologics introduces upward or downward pressure on prices, contingent on interchangeability and substitution policies. Additionally, the global expansion into emerging markets presents expansion opportunities, although pricing strategies must adapt to local regulatory and economic contexts.
Price Projection Analysis
Short-term Outlook (Next 12 months)
Given current patent protections and limited generic competition, prices are expected to remain relatively stable, with potential slight increases driven by inflation and supply chain costs. Market adoption rates, clinician acceptance, and payer negotiations will be critical determinants.
Medium-term Outlook (2-5 years)
Potential entry of biosimilars or generics post-patent expiry could lead to significant price reductions, potentially in the range of 30-50% for the original molecule. Alternatively, extension of patent life through new indications or formulation improvements—such as extended-release versions—might sustain premium pricing.
Long-term Outlook (Beyond 5 years)
If biosimilar competition intensifies and pricing pressures mount, the product's price could stabilize at a reduced level, aligning with global benchmarks. Conversely, strategic investments in novel delivery systems or combination therapies could preserve broader price stability and market share.
Strategic Considerations for Stakeholders
- Manufacturers should prioritize lifecycle management strategies, including formulation innovations and indication expansions, to prolong market exclusivity and sustain valuation.
- Payers are pushing towards value-based pricing, emphasizing outcomes over burden-based reimbursement, which could influence future price ceilings.
- Investors should monitor regulatory developments, patent status, and emerging competitors to anticipate potential valuation shifts.
Key Takeaways
- NDC 64896-0699 enjoys a protected market position due to patent exclusivity, sustaining current pricing levels.
- The competitive landscape remains relatively stable; future pricing will depend heavily on patent expiration and biosimilar entry.
- Evolving regulatory and payer policies are likely to exert downward pressure on prices over the medium term.
- Innovation in formulations or indications can help extend product lifecycle and preserve higher price points.
- Global market expansion offers growth opportunities but requires adaptive pricing strategies due to regional economic factors.
Conclusion
The market landscape for NDC 64896-0699 is characterized by regulatory protection, a limited but competitive environment, and evolving policy pressures. While current prices are supported by patent exclusivity and high demand, emerging competition and healthcare value initiatives suggest a gradual adjustment downward. Stakeholders need to actively manage lifecycle strategies, monitor regulatory shifts, and adapt pricing models to optimize value and sustain profitability.
FAQs
Q1: When is the patent for NDC 64896-0699 set to expire, potentially allowing generic entry?
A: The patent is scheduled to expire in [insert specific year], after which biosimilars or generics may enter the marketplace, typically resulting in substantial price reductions.
Q2: How do biosimilar entries affect the pricing of this drug?
A: Biosimilar entry generally leads to increased market competition, driving prices downward. The extent depends on market acceptance, regulatory approval, and formulary placement.
Q3: What are the major factors influencing the short-term price stability of NDC 64896-0699?
A: Patent protection, supply chain stability, current demand, and minimal competitive pressure contribute to its price stability over the next 12 months.
Q4: How can manufacturers mitigate revenue decline post-patent expiry?
A: By developing new formulations, expanding indications, leveraging biologic enhancements, and engaging in strategic licensing or mergers.
Q5: What international markets represent growth opportunities for this drug?
A: Emerging markets with increasing healthcare infrastructure, less stringent patent enforcement, and unmet medical needs present significant expansion prospects.
Sources:
- FDA National Drug Code Directory.
- IQVIA Market Analytics Reports.
- Industry Patent and Patent Expiry Data.
- Healthcare Policy and Pricing Publications.
- Global Pharmaceutical Industry Databases.
More… ↓
